Miracle Mile Advisors’s Beam Therapeutics BEAM Stock Holding History

Miracle Mile Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$361K	Buy	+10,506	New	+$317K	﹤0.01%	734

Other funds holding BEAM

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Peregrine Investment Management Toronto, Ontario, Canada $235M AUM 131.85% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) Warsaw, Poland $249M AUM 37.04% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

Miracle Mile Advisors's BEAM Position: Q2 2026 in Review

Miracle Mile Advisors opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 10,506 shares worth $361K. The stake represents ﹤0.01% of the portfolio and ranks #734 among its holdings.

37 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Miracle Mile Advisors held 10,506 shares of Beam Therapeutics worth $361K as of Q2 2026.
Beam Therapeutics was a new Miracle Mile Advisors position in Q2 2026.
Beam Therapeutics made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #734 holding.
37 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.